JACQUELINE FRAISER: Open Payments
NPI 1629199633 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 10 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $41 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $38 |
| SOBI, INC | 1 | $29 |
| Karyopharm Therapeutics Inc. | 1 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| SpringWorks Therapeutics, Inc. | 1 | $20 |
| BridgeBio Pharma, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: LYNPARZA, Vonjo, XPOVIO, Xeomin, ERLEADA, Venclexta, Attruby, Kerendia.
Industry payments across MS — which companies pay providers there.
